Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 21, 2025 11:10 ET | Source: Precedence Research

Molecular Diagnostic Market Size to Record USD 542.97 Million By 2034 | Statifacts

Ottawa, April 21, 2025 (GLOBE NEWSWIRE) -- According to Statifacts, the global molecular diagnostic market size was valued at USD 353 million in 2024 and is expected to attain USD 542.97 million by...
August 09, 2023 08:04 ET | Source: Rationalstat LLC

Global Molecular Diagnostic Market is expected to reach US$ 18.6 billion by 2028, registering a CAGR of over 12.1% during 2023-2028

Wilmington,Delaware, Aug. 09, 2023 (GLOBE NEWSWIRE) -- Market Scope and Report Overview Market intelligence for the global molecular diagnostic market covers market sizes on the basis of...
March 17, 2021 07:30 ET | Source: Interpace Biosciences, Inc.

Interpace Biosciences Announces Divestiture of New Haven CLIA lab to DiamiR

Part of Company’s Site Consolidation and Cost Savings Measures Parsippany, NJ, March 17, 2021 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (OTC: IDXG) announced today that it has entered into...
October 06, 2020 16:02 ET | Source: Fluidigm Corporation

Fluidigm Announces Conference Call and Webcast of Third Quarter 2020 Financial Results

SOUTH SAN FRANCISCO, Calif., Oct. 06, 2020 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive...
September 02, 2020 16:02 ET | Source: Fluidigm Corporation

Fluidigm to Participate at the 2020 Cantor Virtual Global Healthcare Conference

SOUTH SAN FRANCISCO, Calif., Sept. 02, 2020 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive...
December 27, 2018 06:55 ET | Source: Interpace Diagnostics Group, Inc.

Interpace Diagnostics Ranked as Top 10 Bioinformatics Solutions Provider

PARSIPPANY, NJ, Dec. 27, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG) announced today that CIO Applications, a publication focused on providing professionals with...
December 11, 2018 09:13 ET | Source: Admera Health, LLC

Admera Health Genetic Tests are Now In-Network with CareFirst BlueCross BlueShield, Maryland, Washington D.C, and Northern Virginia

SOUTH PLAINFIELD, N.J., Dec. 11, 2018 (GLOBE NEWSWIRE) -- Admera Health (www.admerahealth.com), an advanced molecular diagnostics company, announced today that its genetic testing services are now...
November 26, 2018 06:55 ET | Source: Interpace Diagnostics Group, Inc.

Newly Published Data from National Study Supports Interpace Diagnostics’ PancraGEN®

New Article in Peer-Reviewed Journal Highlights Important Role of PancraGEN® Testing PARSIPPANY, NJ, Nov. 26, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG)...
November 07, 2018 08:06 ET | Source: Interpace Diagnostics Group, Inc.

Interpace Diagnostics Announces New Coverage by Blue Cross Blue Shield for Thyroid Testing

The Federal Employee Health Benefit BCBS Program Adds Approximately 5.3 Million Covered Lives PARSIPPANY, NJ, Nov. 07, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG)...
July 27, 2017 16:05 ET | Source: Fluidigm Corporation

Fluidigm and Ascendas Genomics Announce Strategic Partnership to Develop Microfluidic Molecular Diagnostics in China

SOUTH SAN FRANCISCO, Calif. and ZHONGSHAN, China, July 27, 2017 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) and Ascendas Genomics today announced a strategic partnership to develop...